Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about HALO

Recent news which mentions HALO

< Previous 1 2 3 4 5 Next >
The 3 Best Biotech Stocks to Buy in Q2 2024
Tickers BMY HALO LLY
Tags LLY Stocks to Buy HALO
From InvestorPlace
7 Biotech Stocks to Buy as Sector Rotation Ramps Up
Tickers ARWR CRSP CYTK HALO
Tags SWTX HALO Stocks to Buy
From InvestorPlace
Breaking Down Halozyme Therapeutics: 7 Analysts Share Their Views
Tickers HALO
Tags Market News HALO Analyst Ratings
From Benzinga
Halozyme Therapeutics: Q4 Earnings Insights
Tickers HALO
Tags BZI/Recaps Benzinga Earnings
From Benzinga
Earnings Scheduled For February 20, 2024
Tickers ABCL ADEA AIP ALE
Tags BKD CMTG MFIN
From Benzinga
Earnings Preview: Halozyme Therapeutics
Tickers HALO
Tags Earnings HALO Market News
From Benzinga
Gates Ventures, Mayo Clinic Back Tiny Robot Created By $400M Apple Face ID Inventors To Treat Brain Disease
Tickers AAPL HALO ISRG MSFT
Tags OurCrowd Health Care MSFT
From Benzinga
Making Inception A Reality? Prophetic's $2000 AI Headband Promises To Let You Control Dreams
Tickers HALO INTC MSFT NEWS
Tags artificial intelligence MSFT Prophetic
From Benzinga
Bristol Myers' Lead Cancer Drug Opdivo Formulated As Under Skin Injection At Par With Intravenous Infusion In Kidney Cancer Patients
Tickers BMY HALO NEWS
Tags General News HALO
From Benzinga
3 Biotech Stocks to Sell in January Before They Crash and Burn
Tickers HALO MNKD SAVA
Tags Stocks to Sell MNKD SAVA
From InvestorPlace
Halozyme's Ambitious Five-Year Plan: Analysts Optimistic On Growth, Eyeing Market Expansion
Tickers ARGX HALO NEWS
Tags Analyst Ratings General ARGX
From Benzinga
Expert Outlook: Halozyme Therapeutics Through The Eyes Of 4 Analysts
Tickers HALO
Tags Market News HALO Analyst Ratings
From Benzinga
Roche's One Of Largest Selling Cancer Drug Approved Under The Skin Injection Version In Europe
Tickers HALO RHHBY
Tags Benzinga General why it's moving
From Benzinga
4 Magnificent Healthcare Stocks to Buy in 2024 and Beyond
Tickers ABCL CNC HALO HUM
Tags ABCL Market News HALO
From Motley Fool
Expert Outlook: Halozyme Therapeutics Through The Eyes Of 4 Analysts
Tickers HALO
Tags Benzinga BZI/AAR Market News
From Benzinga
7 Underappreciated Biotech Stocks to Pick Up on the Cheap
Tickers BNTX CORT GMAB HALO
Tags KNSA INCY GMAB
From InvestorPlace
Under the Microscope: 3 Biotech Stocks Pioneering Tomorrow’s Cures
Tickers ABOS BMRN EXEL HALO
Tags EXEL ABOS BMRN
From InvestorPlace
3 Promising Biotech Stocks Flying Under the Radar
Tickers ABOS BMRN EXEL HALO
Tags Market News EXEL BMRN
From InvestorPlace
Earnings Scheduled For November 6, 2023
Tickers AAON ACVA ADEA ADTN
Tags PLL SANM EOSE
From Benzinga
Earnings Outlook For Halozyme Therapeutics
Tickers HALO
Tags Earnings Market News BZI/EP
From Benzinga
Millionaire Secrets: 3 Stocks to Turn $1,000 Into a Fortune
Tickers CAE HALO PERI
Tags Stocks to Buy HALO NASDAQ:HALO,NYSE:CAE,NASDAQ:PERI
From InvestorPlace
Opdivo's Subcutaneous Formulation Shows Promise in Advanced Kidney Cancer: Bristol Myers Squibb's Latest Findings
Tickers BMY HALO MRTX
Tags General News Large Cap
From Benzinga
Analyst Expectations for Halozyme Therapeutics's Future
Tickers HALO
Tags Benzinga Market News Analyst Ratings
From Benzinga
7 Sleeper Stocks That Should Be on Every Investor’s Radar This Fall
Tickers EG HALO ITT POWI
Tags ITT EG SYNA
From InvestorPlace
Where Halozyme Therapeutics Stands With Analysts
Tickers HALO
Tags Benzinga BZI/AAR HALO
From Benzinga
Expert Ratings for Halozyme Therapeutics
Tickers HALO
Tags BZI/AAR HALO Market News
From Benzinga
Johnson & Johnson, Other Pharma Makers Anticipate Reformulated Injectable Drugs May Exclude Price Negotiations
Tickers BMY HALO JNJ MRK
Tags Market News RHHBF BMY
From Benzinga
Halozyme's Subcutaneous Drug Delivery: Analysts Initiate With 'Buy' Rating, Say Enhanze Tech Targets $41.7B Market
Tickers HALO
Tags Biotech Initiation General
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 24, 2023
Tickers AA ABR AMLX APP
Tags ABR TWLO JNPR
From Benzinga
Roche's Approved Multiple Sclerosis Drug: Subcutaneous Injection At Par With Intravenous Infusion
Tickers HALO RHHBF RHHBY RHHVF
Tags Benzinga RHHVF Health Care
From Benzinga
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.